Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
8 pending office actions • 5 art units • 7 examiners • 0 of 8 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Cytek Biosciences Inc. has 8 pending office actions in Biotechnology & Pharmaceuticals. The docket spans 7 examiners and 5 art units, demonstrating substantial distribution across both examiner assignments and technical examination groups.
IVICH, FERNANDO NMN is the busiest examiner, with 2 pending matters. The limited concentration around that examiner does not eliminate the need for portfolio-level coordination, particularly for claim language and shared technical disclosures across the assigned units.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (25%) |
| Double-patenting + other | 2 (25%) |
| Multi-statute (no §101) | 4 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| IVICH, FERNANDO NMN | 2 | 52.4% | +72.2% |
| OGUNTADE, ELIZABETH BISOLA | 1 | 50.0% | +100.0% |
| TRAN, CHAU NGUYEN BICH | 1 | 31.6% | +45.2% |
| RAMADAN, OMAR | 1 | 25.4% | +56.5% |
| KWAK, DEAN P | 1 | 58.8% | +37.1% |
| COOK, JONATHON | 1 | 81.6% | +17.1% |
| BRYANT, REBECCA CAROLE | 1 | 64.8% | +32.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17994395 | METHODS, APPARATUS, AND SYSTEMS FOR AN OPTICAL FIBER FORWARD SCATTER CHANNEL IN FLOW CYTOMETERS | COOK, JONATHON | 77d overdue |
| 18297615 | METHODS AND APPARATUS FOR REMOVABLE NOZZLE WITH CAM LATCH ENGAGEMENT IN FLOW CYTOMETERS | KWAK, DEAN P | 44d overdue |
| 16418942 | FAST RECOMPENSATION OF FLOW CYTOMETERY DATA FOR SPILLOVER READJUSTMENTS | BRYANT, REBECCA CAROLE | 14d |
| 18335091 | METHODS AND APARATUS FOR A MOUSE SURFACE AND INTRACELLULAR FLOW CYTOMETRY IMMUNOPHENOTYPING KIT | RAMADAN, OMAR | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17994395 | METHODS, APPARATUS, AND SYSTEMS FOR AN OPTICAL FIBER FORWARD SCATTER CHANNEL IN FLOW CYTOMETERS | COOK, JONATHON | 77d overdue |
| 18297615 | METHODS AND APPARATUS FOR REMOVABLE NOZZLE WITH CAM LATCH ENGAGEMENT IN FLOW CYTOMETERS | KWAK, DEAN P | 44d overdue |
| 16418942 | FAST RECOMPENSATION OF FLOW CYTOMETERY DATA FOR SPILLOVER READJUSTMENTS | BRYANT, REBECCA CAROLE | 14d |
| 18747407 | ULTRA-BRIGHT NANOPARTICLE FLUORESCENT DYE COMPLEXES | IVICH, FERNANDO NMN | — |
| 18539182 | ACCURATE ENUMERATION OF LEUKOCYTE SUBSETS IN PERIPHERAL BLOOD WITH A 15-COLOR IMMUNOPROFILING PANEL USING A SPECTRAL FLOW CYTOMETER | IVICH, FERNANDO NMN | — |
| 18491741 | HIGH PARAMETER 20 COLOR PANEL FOR EFFECTIVE DETECTION OF ABERRANT CELLS IN ACUTE MYELOID LEUKEMIA | OGUNTADE, ELIZABETH BISOLA | — |
| 18353056 | B CELL MONITORING REAGENT PANEL AND REAGENT KIT FOR ANALYZING B CELL SUBSETS IN ANTI-CD20 TREATED AUTOIMMUNE PATIENTS | TRAN, CHAU NGUYEN BICH | — |
| 18335091 | METHODS AND APARATUS FOR A MOUSE SURFACE AND INTRACELLULAR FLOW CYTOMETRY IMMUNOPHENOTYPING KIT | RAMADAN, OMAR | — |
| Art Unit | Apps |
|---|---|
| 1678 | 2 |
| 1677 | 2 |
| 2877 | 2 |
| 1657 | 1 |
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18747407 | ULTRA-BRIGHT NANOPARTICLE FLUORESCENT DYE COMPLEXES | IVICH, FERNANDO NMN | 1657 | §102§112DP | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18539182 | ACCURATE ENUMERATION OF LEUKOCYTE SUBSETS IN PERIPHERAL BLOOD WITH A 15-COLOR IMMUNOPROFILING PANEL USING A SPECTRAL FLOW CYTOMETER | IVICH, FERNANDO NMN | 1678 | §112 | Non-Final OA | — | Pending | Dec 13, 2023 |
| 18491741 | HIGH PARAMETER 20 COLOR PANEL FOR EFFECTIVE DETECTION OF ABERRANT CELLS IN ACUTE MYELOID LEUKEMIA | OGUNTADE, ELIZABETH BISOLA | 1677 | §112 | Final Rejection | — | Pending | Oct 20, 2023 |
| 18353056 | B CELL MONITORING REAGENT PANEL AND REAGENT KIT FOR ANALYZING B CELL SUBSETS IN ANTI-CD20 TREATED AUTOIMMUNE PATIENTS | TRAN, CHAU NGUYEN BICH | 1677 | §103§112DP | Non-Final OA | — | Pending | Jul 14, 2023 |
| 18335091 | METHODS AND APARATUS FOR A MOUSE SURFACE AND INTRACELLULAR FLOW CYTOMETRY IMMUNOPHENOTYPING KIT | RAMADAN, OMAR | 1678 | §102§112 | Non-Final OA | — | Pending | Jun 14, 2023 |
| 18297615 | METHODS AND APPARATUS FOR REMOVABLE NOZZLE WITH CAM LATCH ENGAGEMENT IN FLOW CYTOMETERS | KWAK, DEAN P | 1798 | §102§103§112 | Final Rejection | 44d overdue | Pending | Apr 08, 2023 |
| 17994395 | METHODS, APPARATUS, AND SYSTEMS FOR AN OPTICAL FIBER FORWARD SCATTER CHANNEL IN FLOW CYTOMETERS | COOK, JONATHON | 2877 | §102§103 | Non-Final OA | 77d overdue | Pending | Nov 28, 2022 |
| 16418942 | FAST RECOMPENSATION OF FLOW CYTOMETERY DATA FOR SPILLOVER READJUSTMENTS | BRYANT, REBECCA CAROLE | 2877 | §102§103§112 | Non-Final OA | 14d | Pending | May 21, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCytek Biosciences Inc. has 8 pending office actions as of October 2026, spread across 5 art units and 7 examiners.
Fernando Nmn Ivich has the most, with 2 of Cytek Biosciences Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
